33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512550
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

1 ene 1997 año - Rituximab

Descripción:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
302

fecha:

1 ene 1997 año
Ahora mismo
~ 28 years ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL